Research view
Multiple myeloma: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
- All targets
- BCMA 134
- CD38 22
- GPRC5D 36
- CD19 31
- TP53 0
- STAT3 0
- CXCR4 4
- MYC 0
- BCL-2 2
- PI3K 1
- mTOR 0
- IL-6 0
- STING 0
- BRAF 2
- CD47 1
- HDAC 0
- AKT 0
- PD-1 1
- PD-L1 1
- CD20 3
- GLP-1 0
- JAK 0
- PTEN 0
- SGLT2 0
- AMPK 0
- B7-H3 0
- NRAS 1
- TIGIT 0
- CTLA-4 1
- ERK 0
- EZH2 0
- FTO 0
- IL-15 3
- JNK 0
- KRAS 1
- MAPK 0
- RAS 0
- CD22 2
- CD33 1
- CTNNB1 0
- EGFR 0
- FGFR 0
- LAG-3 0
- MDM2 0
- METTL3 0
- NRF2 0
- BRCA1 0
- BRD4 0
- BTK 1
- CD123 1
- CD30 0
- CDK4/6 0
- GPX4 0
- HER2 0
- HIF-1 0
- HSP90 0
- MEK 0
- MET 0
- MUC1 0
- NTRK 0
EU-13 is a filter, not a ranking: it only narrows the list.
No research groups match this view yet.
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 23
- Organoids 3
- Mendelian Randomization Analysis 10
- CRISPR-Cas Systems 8
- Gene Expression Profiling 44
- Sequence Analysis, RNA 7
- Whole Genome Sequencing 4
- Exome Sequencing 3
- Proteomics 15
- Metabolomics 10
- Mass Spectrometry 7
- Flow Cytometry 48
- Immunohistochemistry 11
- Liquid Biopsy 2
- Circulating Tumor DNA 2
- Xenograft Model Antitumor Assays 78
- Positron-Emission Tomography 14
- Magnetic Resonance Imaging 26
- Machine Learning 17
- Deep Learning 6
- Cohort Studies 32
- Genome-Wide Association Study 7
Clinicopathologic characterization of plasma cell neoplasms with IGH::CCND3.
CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.
The diagnostic utility and frequency of CD56 expression in plasma cell myeloma.
The Association and Significance of MDM2 and NF-κB Protein Expression in Multiple Myeloma.
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.